Related Experiment Video

Updated: May 9, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and

S Timme1, S Ihde1, C D Fichter2

  • 1Institute of Clinical Pathology, University Medical Center, Albert-Ludwigs-University, Freiburg, Germany.

Oncogene
|August 6, 2013
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) plays a role in esophageal cancers. This study found distinct STAT3 activation patterns in ESCC and BAC, impacting cell proliferation and migration differently, suggesting tailored therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is frequently altered in epithelial cancers.
  • STAT3 is a potential therapeutic target in oncology.
  • Esophageal carcinomas comprise two main histotypes: esophageal squamous cell carcinoma (ESCC) and Barrett's adenocarcinoma (BAC).

Purpose of the Study:

  • To investigate STAT3 expression, activity, and cellular functions in ESCC and BAC.
  • To determine the distinct roles of STAT3 in the proliferation and migration of ESCC and BAC cells.
  • To identify novel STAT3-regulated genes involved in esophageal cancer progression.

Main Methods:

  • In situ immunohistochemistry for STAT3 and phosphorylated STAT3 (P-STAT3) in patient samples (n=49 ESCC, n=61 BAC).
  • In vitro studies using ESCC (OE21) and BAC (OE33) cell lines with STAT3 knockdown.
  • Epidermal growth factor (EGF) stimulation assays.
  • Transcriptome analysis to identify STAT3-regulated genes.

Main Results:

  • STAT3 expression was similar in ESCC and BAC, but P-STAT3 was preferentially activated in ESCC.
  • STAT3 knockdown reduced cell proliferation in both ESCC and BAC cells.
  • STAT3 knockdown inhibited cell migration in BAC cells but not in ESCC cells, where it may support migration.
  • STAT3 knockdown downregulated cell cycle genes in both histotypes.
  • Distinct gene expression changes related to cell migration were observed between ESCC and BAC following STAT3 knockdown.

Conclusions:

  • STAT3 exhibits distinct activation patterns and functional roles in ESCC and BAC.
  • STAT3 inhibition reduces proliferation in both esophageal cancer types.
  • STAT3's role in cell migration differs between ESCC and BAC, impacting therapeutic strategies.
  • Novel STAT3-regulated genes involved in proliferation and migration were identified.
  • STAT3 represents a potential therapeutic target, but treatment strategies must consider the specific histotype of esophageal cancer.

More Related Videos

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...